HDAC Inhibitors Repress NUT Carcinoma Function

2026-09-20

This study developed a dCas9-based GFP reporter screen to identify small molecules that suppress NUT-driven transcription and uncovered structurally diverse HDAC inhibitors as potent repressors of NUT function. Panobinostat and IRBM6 reduced megadomain-associated oncogenic transcription, promoted differentiation, and restricted tumor growth in xenograft models, supporting chromatin acetylation as a therapeutic vulnerability in NUT carcinoma.

Icatibant in Viral Infections: Evidence and Limits

2026-09-19

This 2023 letter synthesizes case-based experience with icatibant in severe Puumala hantavirus infection and relates it to bradykinin-mediated vascular leakage in COVID-19. Its main contribution is a mechanistic and clinical rationale for early bradykinin receptor blockade, while its small, uncontrolled evidence base means efficacy remains unproven.

MDV3100 and UGDH: Mapping AR Resistance

2026-09-18

MDV3100 (Enzalutamide) research is strengthened by viewing androgen receptor inhibition alongside UGDH-controlled glycan metabolism. This article translates recent mechanistic findings into assay-design principles for studying resistance in prostate cancer models.

U 46619: From TP Signaling to Translation

2026-09-18

U 46619, also known as 11,9 epoxymethano-prostaglandin H2, is a mechanistically useful TP receptor agonist for resolving how platelet activation and vascular responses evolve across exposure levels. This thought-leadership guide connects assay design, renal and blood-pressure models, and anticoagulation strategy while positioning APExBIO product B6890 as a practical research tool.

Restoring PTEN Signaling with Modified mRNA

2026-09-17

PTEN restoration is emerging as a practical strategy for interrogating PI3K/Akt-driven resistance. This thought-leadership article explains how Cap1 and pseudouridine-modified in vitro transcribed mRNA can support controlled PTEN expression, connects nanoparticle delivery evidence to translational study design, and outlines how EZ Cap™ Human PTEN mRNA (ψUTP) can strengthen cancer research workflows without overstating clinical readiness.

Adefovir-Induced Osteochondrosis Mimicking AS

2026-09-17

This case report shows how long-term Adefovir exposure can produce hypophosphatemic osteochondrosis with sacroiliac imaging findings that resemble ankylosing spondylitis. Its practical contribution is a differential-diagnosis framework linking phosphate and alkaline phosphatase testing with medication history, imaging, and improvement after Adefovir withdrawal.

BH3-Mimetic Targeting in Glioblastoma

2026-09-16

The reference study shows that glioblastoma, including stem-like tumor cell populations, depends on the anti-apoptotic proteins BCL-XL and MCL-1. Its central translational insight is that sequential inhibition of these survival proteins can expose apoptotic vulnerability and produce robust anti-tumor responses in vivo without overt toxicity in the reported models.

Basic Protein Native PAGE Kit: K4142 Guide

2026-09-16

5-Methyl-CTP: From IVT to Vaccine Evidence

2026-09-15

Discover how 5-Methyl-CTP supports modified mRNA synthesis and how its performance should be evaluated beyond transcript yield. This evidence-driven guide connects nucleotide chemistry, analytical controls, and mRNA vaccine studies without overstating what animal data prove.

FLAG tag Peptide Workflows for Protein Purification

2026-09-15

Turn a short DYKDDDDK epitope into a practical control point for recombinant protein capture, gentle elution, detection, and antibody validation. This workflow also connects affinity purification with the fast-dissociation antibody screening strategy reported in single-molecule microscopy research.

Octyl-α-ketoglutarate: A Causal Assay Framework

2026-09-14

Octyl-α-ketoglutarate enables controlled investigation of α-ketoglutarate-dependent HIF-1α regulation. This article presents a causal assay framework linking prolyl hydroxylase activity, IDH biology, and TCA cycle dysfunction research.

Spiroplasma Entry Pathways in Drosophila S2 Cells

2026-09-14

Wei and colleagues developed a Drosophila Schneider 2 cell model to show that Spiroplasma eriocheiris can invade invertebrate cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological disruption further linked infection to functional actin and microtubule networks, creating a useful framework for separating bacterial entry, intracellular accumulation, and host-cell injury.

Etomoxir in Reliable Cell Metabolism Assays

2026-09-13

This scenario-based guide explains how Etomoxir, SKU A3404, can support fatty acid oxidation, immunometabolism, viability, and lipid-assay workflows. It covers concentration selection, solvent controls, interpretation of DGAT activity, whole-blood compatibility, and practical vendor-selection criteria.

MnTBAP Chloride: Reading Mitochondrial ROS

2026-09-12

MnTBAP Chloride is a cell-permeable SOD mimetic for testing how mitochondrial superoxide influences inflammation, energy failure, and disease-like phenotypes. This article translates recent chronic-stress findings into compartment-aware assay and interpretation strategies.

Phosbind Acrylamide for Protein Phosphorylation

2026-09-11

Phosbind Acrylamide converts phosphate-dependent binding into a direct SDS-PAGE mobility readout, reducing reliance on phospho-specific antibodies. This guide shows how to build MnCl2-containing gels, design matched controls, and troubleshoot phosphorylation shifts for AMPKα2, kinase assays, and pathway screens.